Cystic Fibrosis Market

Cystic Fibrosis Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

250

Base Year:

2023

Oct - 2024

Format:

Report Code:

VMR-2777

Segments Covered

By Drug Class Cystic Fibrosis Transmembrane Conductane Regulator (CFTR), Bronchodilators, Mucolytic, Pancreatic Enzyme Supplement, Others
By Route of Administration Oral, Inhalation, Injectable, Others
By Distribution Channel Retail Pharmacies & Drug Stores, Online Pharmacies, Hospital Pharmacies
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2023
Forecast Years:	2024 - 2032
Historical Years:	2018 - 2022
Revenue 2023:	USD 10.4 Billion
Revenue 2032:	USD 55.4 Billion
Revenue CAGR (2024 - 2032):	21.6%
Fastest Growing Region (2024 - 2032)	Asia Pacific
Largest Region (2023):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Cystic Fibrosis Market - Segment Analysis
1. Overview
2. Global Cystic Fibrosis Market, 2016 - 2028 (USD Million)
3. Global Cystic Fibrosis Market - by Drug Class
  1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
  2. By Bronchodilators
  3. By Mucolytic
  4. By Pancreatic Enzyme Supplement
  5. By Others
4. Global Cystic Fibrosis Market - by Route of Administration
  1. By Oral
  2. By Inhalation
  3. By Injectable
  4. By Others
5. Global Cystic Fibrosis Market - by Distribution Channel
  1. By Retail Pharmacies & Drug Stores
  2. By Online Pharmacies
  3. By Hospital Pharmacies
6. Global Cystic Fibrosis Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
7. Market comparative analysis
North America Cystic Fibrosis Market - Segment Analysis
1. Overview
2. North America Cystic Fibrosis Market, 2016 - 2028 (USD Million)
3. North America Cystic Fibrosis Market, by Drug Class
  1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
  2. By Bronchodilators
  3. By Mucolytic
  4. By Pancreatic Enzyme Supplement
  5. By Others
4. North America Cystic Fibrosis Market, by Route of Administration
  1. By Oral
  2. By Inhalation
  3. By Injectable
  4. By Others
5. North America Cystic Fibrosis Market, by Distribution Channel
  1. By Retail Pharmacies & Drug Stores
  2. By Online Pharmacies
  3. By Hospital Pharmacies
6. North America Cystic Fibrosis Market, by Country
  1. U.S.
    1. U.S. Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. U.S. Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. U.S. Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
  2. Canada
    1. Canada Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. Canada Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. Canada Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
  3. Mexico
    1. Mexico Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. Mexico Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. Mexico Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
Europe Cystic Fibrosis Market - Segment Analysis
1. Overview
2. Europe Cystic Fibrosis Market, 2016 - 2028 (USD Million)
3. Europe Cystic Fibrosis Market, by Drug Class
  1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
  2. By Bronchodilators
  3. By Mucolytic
  4. By Pancreatic Enzyme Supplement
  5. By Others
4. Europe Cystic Fibrosis Market, by Route of Administration
  1. By Oral
  2. By Inhalation
  3. By Injectable
  4. By Others
5. Europe Cystic Fibrosis Market, by Distribution Channel
  1. By Retail Pharmacies & Drug Stores
  2. By Online Pharmacies
  3. By Hospital Pharmacies
6. Europe Cystic Fibrosis Market, by Country
  1. Germany
    1. Germany Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. Germany Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. Germany Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
  2. UK
    1. UK Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. UK Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. UK Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
  3. France
    1. France Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. France Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. France Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
  4. Spain
    1. Spain Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. Spain Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. Spain Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
  5. Italy
    1. Italy Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. Italy Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. Italy Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
  6. BENELUX
    1. BENELUX Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. BENELUX Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. BENELUX Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
  7. Rest of Europe
    1. Rest Of Europe Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. Rest Of Europe Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. Rest Of Europe Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
Asia Pacific Cystic Fibrosis Market - Segment Analysis
1. Overview
2. Asia Pacific Cystic Fibrosis Market, 2016 - 2028 (USD Million)
3. Asia Pacific Cystic Fibrosis Market, by Drug Class
  1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
  2. By Bronchodilators
  3. By Mucolytic
  4. By Pancreatic Enzyme Supplement
  5. By Others
4. Asia Pacific Cystic Fibrosis Market, by Route of Administration
  1. By Oral
  2. By Inhalation
  3. By Injectable
  4. By Others
5. Asia Pacific Cystic Fibrosis Market, by Distribution Channel
  1. By Retail Pharmacies & Drug Stores
  2. By Online Pharmacies
  3. By Hospital Pharmacies
6. Asia Pacific Cystic Fibrosis Market, by Country
  1. China
    1. China Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. China Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. China Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
  2. Japan
    1. Japan Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. Japan Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. Japan Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
  3. India
    1. India Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. India Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. India Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
  4. South Korea
    1. South Korea Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. South Korea Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. South Korea Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
  5. South East Asia
    1. South East Asia Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. South East Asia Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. South East Asia Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. Rest of Asia Pacific Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. Rest of Asia Pacific Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
Latin America Cystic Fibrosis Market - Segment Analysis
1. Overview
2. Latin America Cystic Fibrosis Market, 2016 - 2028 (USD Million)
3. Latin America Cystic Fibrosis Market, by Drug Class
  1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
  2. By Bronchodilators
  3. By Mucolytic
  4. By Pancreatic Enzyme Supplement
  5. By Others
4. Latin America Cystic Fibrosis Market, by Route of Administration
  1. By Oral
  2. By Inhalation
  3. By Injectable
  4. By Others
5. Latin America Cystic Fibrosis Market, by Distribution Channel
  1. By Retail Pharmacies & Drug Stores
  2. By Online Pharmacies
  3. By Hospital Pharmacies
6. Latin America Cystic Fibrosis Market, by Country
  1. Brazil
    1. Brazil Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. Brazil Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. Brazil Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
  2. Argentina
    1. Argentina Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. Argentina Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. Argentina Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
  3. Rest of Latin America
    1. Rest of Latin America Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. Rest of Latin America Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. Rest of Latin America Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
Middle East & Africa Cystic Fibrosis Market - Segment Analysis
1. Overview
2. Middle East & Africa Cystic Fibrosis Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Cystic Fibrosis Market, by Drug Class
  1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
  2. By Bronchodilators
  3. By Mucolytic
  4. By Pancreatic Enzyme Supplement
  5. By Others
4. Middle East & Africa Cystic Fibrosis Market, by Route of Administration
  1. By Oral
  2. By Inhalation
  3. By Injectable
  4. By Others
5. Middle East & Africa Cystic Fibrosis Market, by Distribution Channel
  1. By Retail Pharmacies & Drug Stores
  2. By Online Pharmacies
  3. By Hospital Pharmacies
6. Middle East & Africa Cystic Fibrosis Market, by Country
  1. GCC Countries
    1. GCC Countries Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. GCC Countries Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. GCC Countries Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
  2. South Africa
    1. South Africa Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. South Africa Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. South Africa Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Cystic Fibrosis Market, By Drug Class
      1. By Cystic Fibrosis Transmembrane Conductane Regulator (CFTR)
      2. By Bronchodilators
      3. By Mucolytic
      4. By Pancreatic Enzyme Supplement
      5. By Others
    2. Rest of Middle East & Africa Cystic Fibrosis Market, By Route of Administration
      1. By Oral
      2. By Inhalation
      3. By Injectable
      4. By Others
    3. Rest of Middle East & Africa Cystic Fibrosis Market, By Distribution Channel
      1. By Retail Pharmacies & Drug Stores
      2. By Online Pharmacies
      3. By Hospital Pharmacies
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Vertex Pharmaceuticals Incorporated
2. AbbVie Inc.
3. Gilead Sciences Inc.
4. Genentech Inc.
5. Novartis AG
6. Teva Pharmaceutical Industries Ltd.
7. Mylan N.V.
8. Perrigo Company plc
9. Pharmaxis Ltd.
10. Celtaxsys Inc.
11. Savara Inc.
12. Kamada Ltd.
13. Chiesi Farmaceutici S.p.A.
14. Galapagos NV
15. Proteostasis Therapeutics Inc.
16. Eloxx Pharmaceuticals Inc.
17. Insmed Incorporated
18. Arcturus Therapeutics Holdings Inc.
19. Translate Bio Inc.
20. Zogenix Inc.
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

FAQ

Frequently Asked Question

What is the global demand for Cystic Fibrosis in terms of revenue?

The global Cystic Fibrosis valued at USD 10.4 Billion in 2023 and is expected to reach USD 55.4 Billion in 2032 growing at a CAGR of 21.6%.

Which are the prominent players in the market?

The prominent players in the market are Vertex Pharmaceuticals Incorporated, AbbVie Inc., Gilead Sciences, Inc., Genentech, Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Perrigo Company plc, Pharmaxis Ltd., Celtaxsys, Inc., Savara Inc., Kamada Ltd., Chiesi Farmaceutici S.p.A., Galapagos NV, Proteostasis Therapeutics, Inc., Eloxx Pharmaceuticals, Inc., Insmed Incorporated, Arcturus Therapeutics Holdings Inc., Translate Bio, Inc.,Zogenix, Inc..

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 21.6% between 2024 and 2032.

What are the driving factors fueling the growth of the market.

The driving factors of the Cystic Fibrosis include

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Cystic Fibrosis in 2023.

Cystic Fibrosis Market

Cystic Fibrosis Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Cystic Fibrosis in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Vantage Market Research

Products & Services

Media

Contact Us

Cystic Fibrosis Market

Cystic Fibrosis Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Cystic Fibrosis in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Cystic Fibrosis Market

Vantage Point Interactive Dashboard